Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3249554
Max Phase: Preclinical
Molecular Formula: C44H71N13O10
Molecular Weight: 942.13
Molecule Type: Protein
Associated Items:
ID: ALA3249554
Max Phase: Preclinical
Molecular Formula: C44H71N13O10
Molecular Weight: 942.13
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)CN(C)C(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC)C(C)C)[C@@H](C)CC)C(=O)O
Standard InChI: InChI=1S/C44H71N13O10/c1-9-25(5)36(41(64)53-32(19-28-20-48-23-50-28)42(65)57(8)22-34(60)54-37(43(66)67)26(6)10-2)56-39(62)31(18-27-13-15-29(58)16-14-27)52-40(63)35(24(3)4)55-38(61)30(51-33(59)21-47-7)12-11-17-49-44(45)46/h13-16,20,23-26,30-32,35-37,47,58H,9-12,17-19,21-22H2,1-8H3,(H,48,50)(H,51,59)(H,52,63)(H,53,64)(H,54,60)(H,55,61)(H,56,62)(H,66,67)(H4,45,46,49)/t25-,26-,30-,31-,32-,35-,36-,37-/m0/s1
Standard InChI Key: VHDVNIBFSSUOPH-JVSOWVDMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 942.13 | Molecular Weight (Monoisotopic): 941.5447 | AlogP: -1.42 | #Rotatable Bonds: 29 |
Polar Surface Area: 355.05 | Molecular Species: ZWITTERION | HBA: 12 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.97 | CX Basic pKa: 11.48 | CX LogP: -3.47 | CX LogD: -4.41 |
Aromatic Rings: 2 | Heavy Atoms: 67 | QED Weighted: 0.03 | Np Likeness Score: -0.17 |
1. Moore GJ, Oudeman EM, Ko D, Nystrom DM.. (1979) Synthesis of angiotensin II antagonists containing sarcosine in position 7., 22 (9): [PMID:490564] [10.1021/jm00195a032] |
Source(1):